medigraphic.com
SPANISH

Anales de Otorrinolaringología Mexicana

Anales de Otorrinolaringología Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 1

Next >>

Otorrinolaringología 2024; 69 (1)

Application of the SNOT-22 questionnaire in patients with a history of COVID-19 in the ENT office of a third level hospital

Maldonado AVG, Aguilar MNE
Full text How to cite this article

Language: Spanish
References: 15
Page: 1-6
PDF size: 288.31 Kb.


Key words:

SNOT-22, COVID-19, SARS-CoV-2, Quality of life.

ABSTRACT

Objective: To establish the most frequent sinonasal manifestations that have the greatest impact on quality of life in patients who attended the otorhinolaryngology outpatient clinic with a history of SARS-CoV-2 infection through the SNOT-22 questionnaire.
Materials and Methods: An observational, descriptive and cross-sectional study, in which the SNOT-22 questionnaire was applied to all patients with a history of SARS-CoV-2 (COVID-19) infection who attended the otorhinolaryngology outpatient clinic from January to December 2022 at the Villahermosa Regional Hospital, Tabasco, and Central Sur Hospital of High Specialty, Mexico City.
Results: One hundred twelve patients were included. The average age was 48.22 years. The main reason for consultation was hyaline rhinorrhea (54.5%). The symptoms with the highest scores were: need to blow nose, nasal congestion/obstruction, taste/smell disturbances, decreased performance/productivity, and poor sleep at night.
Conclusions: It is important to know the manifestations and sequelae that COVID-19 infection can have in the population and how they affect their quality of life in order to provide comprehensive and multidisciplinary management to our patients.


REFERENCES

  1. Izquierdo-Dominguez A, Rojas-Lechuga MJ, Mullol J, Alobid I. Olfactory dysfunction in the covid-19 outbreak.J Investig Allergol Clin Immunol 2020; 30 (5): 317-26. doi: 10.18176/jiaci.0567.

  2. Goyal R, Kapoor A, Goyal MK, Singh R. Alteration of smell and taste sensations in Covid-19 positive patients:A prospective cohort study in Western India. Indian J Otolaryngol Head Neck Surg 2021; 73 (3): 371-7.https://doi.org/10.1007/s12070-021-02670-1.

  3. Liu M, Liu J, Weitzel EK, Chen PG. The predictive utility of the 22-item sino-nasal outcome test (SNOT-22):A scoping review. Int Forum Allergy Rhinol 2022; 12 (1): 83-102. doi: 10.1002/alr.22888.

  4. Bajpai S, Samanth R, Shenoy V, Kudlu K, Bhat S, Islam FN, et al. Otorhinolaryngology symptom assessmentusing SNOT 22 among SARS CoV-2 a. Indian J Otolaryngol Head Neck Surg 2022; 75 (s1): 793-9. https://doi.org/10.1007/s12070-022-03340-6.

  5. Lerner DK, Garvey KL, Arrighi-Allisan AE, Filimonov A, Filip P, Shah J, et al. Clinical features of parosmiaassociated with COVID-19 infection. Laryngoscope 2022; 132 (3): 633-9. doi: 10.1002/lary.29982.

  6. Majumder J, Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPSJ 2021; 23 (1). doi: 10.1208/s12248-020-00532-2.

  7. Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission,diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 2020; 96 (1142): 753-8.doi: 10.1136/postgradmedj-2020-138234.

  8. Pradhan M, Shah K, Alexander A, Ajazuddin, Minz S, Singh MR, et al. COVID-19: clinical presentation anddetection methods. J Immunoass Immunochem 2022; 43 (1). https://doi.org/10.1080/15321819.2021.1951291.

  9. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal OutcomeTest. Clin Otolaryngol 2009; 34 (5): 447-54. doi: 10.1111/j.1749-4486.2009.01995.x.

  10. Gonçalves LF, Gonzáles AI, Paiva KM, Patatt FSA, Stolz JV, Haas P. Smell and taste alterations in COVID-19patients: A systematic review. Rev Assoc Med Bras 2021; 66 (11): 1602-8. https://doi.org/10.1590/1806-9282.66.11.1602.

  11. Raad RA, Ganti A, Goshtasbi K, Lehrich BM, Papagiannopoulos P, LoSavio P, et al. Temporal patterns ofnasal symptoms in patients with mild severity SARS-CoV-2 infection. Am J Otolaryngol 2021; 42 (6). doi:10.1016/j.amjoto.2021.103076.

  12. Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo AV, Antonucci P, Capriotti V, et al. Self-reported smell andtaste recovery in coronavirus disease 2019 patients: a one-year prospective study. Eur Arch Oto-Rhino-Laryngology 2022; 279 (1): 515-20. https://doi.org/10.1007/s00405-021-06839-w.

  13. Lechien JR, Ducarme M, Place S, Chiesa-Estomba CM, Khalife M, De Riu G, et al. Objective olfactory findingsin hospitalized severe COVID-19 patients. Pathogens 2020; 9 (8): 1-6. doi: 10.3390/pathogens9080627.

  14. Raad RA, Ganti A, Goshtasbi K, Lehrich BM, Papagiannopoulos P, LoSavio P, et al. Temporal patterns ofnasal symptoms in patients with mild severity SARS-CoV-2 infection. Am J Otolaryngol 2021; 42 (6). doi:10.1016/j.amjoto.2021.103076.

  15. Song J, Deng YK, Wang H, Wang ZC, Liao B, Ma J, et al. Self-reported taste and smell disorders in patientswith COVID-19: Distinct features in China. Curr Med Sci 2020; 41 (1): 14-23. doi: 10.1007/s11596-021-2312-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Otorrinolaringología. 2024;69